Wenxin He

EGFR L858R mutation is associated with lung adenocarcinoma patients with dominant ground-glass opacity

Yong Yang, Yang Yang, Xiao Zhou et al. · Lung Cancer · 2015 · 84 citations

Medicine, Genetics, Oncology +12

Optimal Lymph Node Examination and Adjuvant Chemotherapy for Stage I Lung Cancer

Jie Dai, Ming Liu, Yang Yang et al. · Journal of Thoracic Oncology · 2019 · 81 citations · Full text

Medicine, Oncology, Surgery +16

Discrepancy of epidermal growth factor receptor mutation in lung adenocarcinoma presenting as multiple ground-glass opacities

Ming Liu, Wenxin He, Nan Song et al. · European Journal of Cardio-Thoracic Surgery · 2016 · 80 citations · Full text

Medicine, Oncology, Pathology +14

Safety and effectiveness of neoadjuvant PD-1 inhibitor (toripalimab) plus chemotherapy in stage II–III NSCLC (LungMate 002): an open-label, single-arm, phase 2 trial

Xinsheng Zhu, Liangdong Sun, Nan Song et al. · BMC Medicine · 2022 · 67 citations · Full text

Medicine, Oncology, Pharmacology +17

Neoadjuvant Sintilimab and Chemotherapy for Resectable Stage IIIA Non-Small Cell Lung Cancer

Peng Zhang, Jie Dai, Fenghuan Sun et al. · The Annals of Thoracic Surgery · 2022 · 59 citations

Medicine, Oncology, Chemotherapy +11